Principal coordinate analysis also showed that bacteria from 4-DEX-treated SR-Gut-aGVHD were distinguishable from those of 1-DEX-treated Gut-aGVHD recipients or non-GVHD recipient, and IL-22-deficiency in donor T cells reduced the difference (Fig. 3b). Here, IL22 is linked to graft versus host disease.